Literature DB >> 26379105

Telomerase: a target for colorectal cancer treatment?

Elias Kouroumalis1.   

Abstract

Entities:  

Year:  2015        PMID： 26379105      PMCID： PMC4825774          DOI： 10.1080/15384101.2015.1032638

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study.

Authors:  Pascal Gervaz; Pascal Bucher; Isabelle Neyroud-Caspar; Claudio Soravia; Philippe Morel
Journal:  Dis Colon Rectum       Date:  2005-02       Impact factor: 4.585

Review 2.  Colorectal carcinogenesis--update and perspectives.

Authors:  Hans Raskov; Hans-Christian Pommergaard; Jakob Burcharth; Jacob Rosenberg
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Differences in telomerase activity between colon and rectal cancer.

Authors:  Georgios D Ayiomamitis; George Notas; Apostolos Zaravinos; Adamantia Zizi-Sermpetzoglou; Maria Georgiadou; Ourania Sfakianaki; Elias Kouroumallis
Journal:  Can J Surg       Date:  2014-06       Impact factor: 2.089

4.  Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis.

Authors:  Cinzia Azzoni; Lorena Bottarelli; Nicoletta Campanini; Gabriella Di Cola; Giovanni Bader; Antonio Mazzeo; Carlo Salvemini; Silvia Morari; Davide Di Mauro; Enrico Donadei; Luigi Roncoroni; Cesare Bordi; Leopoldo Sarli
Journal:  Int J Colorectal Dis       Date:  2006-09-21       Impact factor: 2.571

5.  Reduced hTERT protein levels are associated with DNA aneuploidy in the colonic mucosa of patients suffering from longstanding ulcerative colitis.

Authors:  Mariann Friis-Ottessen; Paula M De Angelis; Aasa R Schjølberg; Solveig N Andersen; Ole Petter F Clausen
Journal:  Int J Mol Med       Date:  2014-03-20       Impact factor: 4.101

6.  Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activity.

Authors:  Georgios D Ayiomamitis; George Notas; Apostolos Zaravinos; Ioannis Drygiannakis; Maria Georgiadou; Ourania Sfakianaki; Niki Mastrodimou; Kyriaki Thermos; Elias Kouroumalis
Journal:  Oncoscience       Date:  2014-06-30

7.  Silencing of the hTERT gene by shRNA inhibits colon cancer SW480 cell growth in vitro and in vivo.

Authors:  Ai-Qun Liu; Lian-Ying Ge; Xiao-Ling Lu; Xiao-Ling Luo; Yan-Ling Cai; Xing-Qing Ye; Fang-Fang Geng
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.